Aquestive Therapeutics
Jenna Klingle has a background in pharmacovigilance and safety, with experience working at Aquestive Therapeutics and Pfizer. Jenna has demonstrated expertise in providing guidance on pharmacovigilance activities outlined by procedures and ensuring adherence to regulatory requirements. Prior to their current roles, Jenna also worked at iQor as a Senior Agent, focusing on compliance audits and training development. Jenna holds a Bachelor of Arts in Sociology from Moravian University.
This person is not in any offices
Aquestive Therapeutics
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.